Mayur Ian Somaiya insider trades

Open-market stock purchases and sales by Mayur Ian Somaiya, Chief Financial Officer at NewAmsterdam Pharma Co NV, from SEC Form 4 filings since Apr 11, 2019.

Recent trades

DateStockTradeValue
Jan 21, 2026NAMS NewAmsterdam Pharma Co NVSold$513K
Jan 21, 2026NAMS NewAmsterdam Pharma Co NVSold$823K
Jan 21, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Jan 20, 2026NAMS NewAmsterdam Pharma Co NVSold$27.6K
Jan 20, 2026NAMS NewAmsterdam Pharma Co NVSold$1.3M
Jan 20, 2026NAMS NewAmsterdam Pharma Co NVSold$635K
Jan 20, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Jan 7, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Jan 7, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Jan 5, 2026NAMS NewAmsterdam Pharma Co NVSold$170K

Companies traded

  • NAMS NewAmsterdam Pharma Co NV: 10 sales, last Jan 21, 2026
  • TCRR Tcr2 Therapeutics Inc: 3 sales, last Dec 14, 2020

Get free alerts when Mayur Ian Somaiya files a new trade →